RFK Jr. Says New HHS Decisions No Longer Required to Be Open for Public...
Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis
PFAS ‘Forever Chemicals’ Worthy Of Public Concern, Expert Says
Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide
Increase in NAION associated with semaglutide use among individuals with type 2 diabetes
Probability of Cardiovascular Events Lower in Type 1 Diabetes Versus Type 2
Type 1 diabetes associated with less myocardial infarction, percutaneous coronary intervention, stroke, and limb ischemia
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
Modestly lower risk for depression seen compared with DPP-4i use, but not compared with SGLT-2i use
Diabetes, Dyslipidemia Screening Rates Low After Pregnancy, Even for Those With HTN, GDM
Although screening rates are higher for exposed individuals, rates are low in both exposed and unexposed individuals
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Recent Decade Saw Rise in Number of Adults With Severe Obesity
Additionally, small increases seen in the percentage of children and adolescents with obesity
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog administered subcutaneously five to 10 minutes before mealtime helps improve glycemic control
